发明授权
US06380188B1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
失效
磺酰基烷酰氨基羟乙氨基磺酰胺逆转录病毒蛋白酶抑制剂
- 专利标题： Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
- 专利标题（中）： 磺酰基烷酰氨基羟乙氨基磺酰胺逆转录病毒蛋白酶抑制剂
-
申请号： US09672449申请日： 2000-09-29
-
公开(公告)号： US06380188B1公开(公告)日： 2002-04-30
- 发明人: Daniel P. Getman , Gary A. DeCrescenzo , John N. Freskos , Michael L. Vazquez , James A. Sikorski , Balekudru Devadas , Srinivasan Nagaraian , Joseph J. McDonald
- 申请人： Daniel P. Getman , Gary A. DeCrescenzo , John N. Freskos , Michael L. Vazquez , James A. Sikorski , Balekudru Devadas , Srinivasan Nagaraian , Joseph J. McDonald
- 主分类号： A61K31343
- IPC分类号： A61K31343
摘要：
Selected sulfonylalkanoylamino hydroxyethylamine sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, relates to selected novel compounds, composition and method for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease, prophylactically preventing retroviral infection or the spread of a retrovirus, and treatment of a retroviral infection.